NCT05886920 · Recruiting
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Start your clinical trial request

Sign in to choose who this request is for, add supporting documents, and send it to our clinical team.

Your request is reviewed and a WeTrials Clinical Navigator will contact you in 1–2 business days. Your profiles and documents stay private to you.

New to WeTrials? Continuing creates your account.